<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Psychogenic nonepileptic seizures: Management and prognosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Psychogenic nonepileptic seizures: Management and prognosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Psychogenic nonepileptic seizures: Management and prognosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Roderick Duncan, MD, PhD, FRCP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Garcia, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 15, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3511388765">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Psychogenic nonepileptic seizures (PNES) are nonepileptic events resembling seizures or syncopal attacks. The management and prognosis of PNES are discussed in this review. The etiology, epidemiology, clinical manifestations, and diagnosis of PNES are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Other nonepileptic paroxysmal disorders are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2230.html" rel="external">
          "Nonepileptic paroxysmal disorders in adolescents and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4111450355">
         <span class="h1">
          CLINICAL MANIFESTATIONS AND DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology, epidemiology, clinical manifestations, and diagnosis of PNES are reviewed here briefly and discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PNES are events thought to have mainly psychologic origins. They clinically mimic epileptic seizures or syncope but are
         <strong>
          not
         </strong>
         associated with abnormal neuronal activity, epileptiform activity on EEG, or reduced perfusion to the brain. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Etiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PNES include a variety of clinical manifestations, some of which are suggestive, although not independently diagnostic, in distinguishing PNES from other differential diagnoses  (
         <a class="graphic graphic_table graphicRef131637 graphicRef131638" href="/z/d/graphic/131637.html" rel="external">
          table 1A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of PNES is generally established by video-electroencephalography (EEG) monitoring, in which captured clinical events are examined in conjunction with EEG activity. Other tests (interictal EEG, neuroimaging, and laboratory studies) are used primarily to investigate alternative etiologies and are not diagnostic of PNES. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H452533804">
         <span class="h1">
          EXPLAINING THE DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3838478225">
         <span class="h2">
          Challenges
         </span>
         <span class="headingEndMark">
          —
         </span>
         Presenting the diagnosis of PNES to patients can be challenging and should not be done until the diagnostic evidence is as good as it can be [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
         Published strategies for communicating the diagnosis of PNES to patients [
         <a href="#rid3">
          3-7
         </a>
         ] have elements in common. Adverse responses do occur, including anger (which may be prognostically bad) [
         <a href="#rid8">
          8,9
         </a>
         ] and exacerbation of events [
         <a href="#rid8">
          8,10
         </a>
         ]. What the content of the conversation is will depend on what tests have been carried out, what interventions are proposed, and other factors.
        </p>
        <p class="headingAnchor" id="H4289592978">
         <span class="h2">
          Our approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following scheme approximately summarizes the author's practice. Note that while causes are mentioned in a general way, no questions regarding causes specific to the patient are asked at this early stage.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Go through the description of the events with the patient and caregiver and confirm that the recorded events are the same as the habitual events.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Explain how electroencephalography (EEG) works and how the recording of events has led to the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Explain that the events are related to emotional or psychological issues, or to past or present factors in the patient's life, but are not due to a medical condition, specifically not epilepsy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Volunteer potential causes, being clear that "specimen" causes (ie, examples) are being discussed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Volunteer that this type of event is seen commonly and happens to ordinary people.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Volunteer that you understand that the events are not under conscious control, but that patients can learn to control them.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Volunteer that while patients may have high levels of anxiety or have low mood, the events are not associated with psychiatric illness, and that you do not consider that the patient is "crazy."
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Explain that the events are not amenable to drug treatment, but that psychological intervention is used. Describe what psychological intervention is likely to consist of.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3333082249">
         <span class="h2">
          Therapeutic implications
         </span>
         <span class="headingEndMark">
          —
         </span>
         One striking characteristic of PNES as a disorder is that a significant minority of patients, varying from 17 to 40 percent [
         <a href="#rid1">
          1,5,10-17
         </a>
         ], stop having events on delivery of the diagnosis. The evidence for this is observational, though examination of the timing of cessation of events suggests that the delivery of the diagnosis is causal [
         <a href="#rid18">
          18
         </a>
         ]. There is also convincing evidence that some aspects of health care utilization improve (ie, demand for health services is reduced) at the same time [
         <a href="#rid19">
          19-21
         </a>
         ], even in some patients in whom the PNES do not [
         <a href="#rid10">
          10
         </a>
         ]. This includes emergency health care. We have no good information on what aspects of the diagnosis conversation are likely to be the most therapeutic. In this regard, it is striking that the study with the lowest remission rate [
         <a href="#rid5">
          5
         </a>
         ] also found that their information was rated by patients as highly acceptable and understandable.
        </p>
        <p class="headingAnchor" id="H233674031">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neurologic follow-up is required for all patients with both PNES and epileptic seizures. It is also required for patients with a diagnosis of "PNES only" to monitor the safe withdrawal of antiseizure medications, answer patient questions, and reinvestigate if new events appear.
        </p>
        <p class="headingAnchor" id="H2207509956">
         <span class="h2">
          Coordination among caregivers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maintenance of communication among neurologic, psychiatric, and primary care providers is required for optimal care of patients with PNES. This communication minimizes the potential for mixed and conflicting messages from different clinicians to contribute to poor outcome [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         The neurologist can be regarded as the "guardian" of the diagnosis of PNES. Patients who have been given a diagnosis of PNES may express a lack of understanding of the diagnosis, despite a thorough diagnostic discussion that the patient reported to have understood at the time [
         <a href="#rid8">
          8,22
         </a>
         ]. Patients may also report new and different events or may describe new symptoms to the psychologist or psychiatrist that cause diagnostic concern. In these circumstances, it is advised that the psychologist or psychiatrist suspend treatment (which will not, in any event, make progress while there is diagnostic doubt in the mind of the patient, relatives, or the clinician) and promptly send the patient back to the neurologist for further explanation or evaluation. Criteria for this step should be agree beforehand as part of a management plan. Some experts advise that patients with PNES only (no epilepsy) should not be discharged from the neurologist's care until the patient, family, and caregivers accept the fact that the patient does not have epilepsy; neurologic care can then be discontinued once patient has safely withdrawn from antiseizure medication and has fully transitioned to psychiatric care [
         <a href="#rid2">
          2,23
         </a>
         ]. However, offering follow-up to patients who are completely unwilling to accept the diagnosis is counterproductive, in our experience, as it undermines the "no epilepsy" part of the diagnostic message. It is also our experience that when patients do not accept the diagnosis, they are often unwilling to attend follow-up in any event.
        </p>
        <p class="headingAnchor" id="H471804522">
         <span class="h2">
          Withdrawal of antiseizure medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients on antiseizure medication who have a diagnosis of PNES only (ie, no epilepsy), antiseizure medication should be gradually withdrawn [
         <a href="#rid4">
          4
         </a>
         ]. The perceived risk of uncovering an unrecognized controlled epilepsy will vary from patient to patient. One study found that in patients with the following characteristics, the risk of an emerging epilepsy on withdrawal was low [
         <a href="#rid24">
          24
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         All current types of event described by patient and eyewitnesses recorded and identified as PNES
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No descriptions of past events raising suspicion of epilepsy rather than PNES
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No history of events during childhood
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No interictal epileptiform abnormalities on electroencephalography (EEG)
        </p>
        <p>
        </p>
        <p>
         The highest risk for seizure relapse in patients was within the initial several months after discontinuation of antiseizure medication therapy [
         <a href="#rid24">
          24
         </a>
         ]. Therefore, supervision of withdrawal should be close during this period, and patients should be advised to report any events different from the recent (diagnosed as PNES) events. Any such events may have to be recorded on video EEG.
        </p>
        <p>
         There is a tendency for physicians who diagnose patients with PNES only to leave them on antiseizure medications "just in case" of an underlying epilepsy. However, leaving a patient on antiseizure medications tends to undermine a "PNES only" diagnostic message and makes therapy difficult. Early withdrawal of antiseizure medications may be associated with some benefits, including decreased use of rescue antiseizure medication treatment, less emergency health care utilization, and higher employment rates at 18 months [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3989797854">
         <span class="h2">
          Neuropsychological testing and psychiatric evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Psychometric testing can be helpful in identifying or defining cognitive deficits (eg, low intelligence quotient, poor executive function) that might guide or impact the success of interventions. A broader neuropsychological assessment can also identify comorbidities requiring treatment in themselves, such as anxiety and depression, and can identify potential causal factors and targets for intervention [
         <a href="#rid26">
          26
         </a>
         ]. Psychiatric evaluation can elicit clinical features that may establish a diagnosis of depression, anxiety, somatic symptom disorder, a dissociative disorder, and other disorders [
         <a href="#rid4">
          4,27-30
         </a>
         ]. Psychological or psychiatric evaluation may establish rapport that allows disclosure of traumatic events, which may be targets for intervention. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis", section on 'Psychopathology'
         </a>
         .).
        </p>
        <p>
         What is done in practice often reflects local availability of services and the willingness of patients to be referred. We offer psychiatric referral and would refer for psychometric testing if a relevant cognitive deficit is suspected.
        </p>
        <p class="headingAnchor" id="H2828460999">
         <span class="h1">
          INTERVENTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H889689975">
         <span class="h2">
          Psychotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although some patients stop having events on being given the diagnosis of PNES (see
         <a class="local">
          'Therapeutic implications'
         </a>
         above), many continue to do so and require treatment. Psychotherapies are the mainstay of treatment, delivered by a psychologist or psychiatrist.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cognitive behavioral therapy
         </strong>
         – Cognitive behavioral therapy (CBT) is a widely used brief psychosocial intervention that is composed of a variety of therapeutic approaches. Observational case series and small randomized trials suggested that CBT might be helpful in reducing seizures and improving psychosocial functioning [
         <a href="#rid31">
          31-35
         </a>
         ]. However, a reasonably large randomized trial of 368 patients found that a PNES-specific CBT approach was not effective in reducing event frequency or severity [
         <a href="#rid36">
          36
         </a>
         ]. Some secondary outcomes, such as quality of life, psychosocial functioning, and others were significantly better in the treatment arm, suggesting that CBT may nonetheless have some non-seizure-specific benefits.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mindfulness-based therapy
         </strong>
         – Mindfulness-based therapy (MBT) may be beneficial for patients who have PNES, but data are sparse. Basic elements of mindfulness meditation include self-regulation of attention and taking a nonjudgmental stance towards one's experience. One observational study enrolled 49 patients with PNES in a 12-session MBT program [
         <a href="#rid37">
          37
         </a>
         ]. At study conclusion, the 12-session program was completed by 26 patients; in this group, a 50 percent or greater reduction in PNES frequency was self-reported by 70 percent, and remission of PNES was reported by 50 percent. The high drop-out rate limits the strength of these findings. (See
         <a class="medical medical_review" href="/z/d/html/103407.html" rel="external">
          "Complementary and alternative treatments for anxiety symptoms and disorders: Physical, cognitive, and spiritual interventions", section on 'Mindfulness meditation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Traditional psychotherapy
         </strong>
         – Traditional psychotherapy has been used in patients with PNES with mixed success [
         <a href="#rid16">
          16,38,39
         </a>
         ]. Group therapy sessions also employ traditional psychodynamic or psychoeducational techniques, and small observational studies have reported decreased episode frequency and/or improvement in psychosocial comorbidities in some patients with PNES [
         <a href="#rid40">
          40-44
         </a>
         ]. The high prevalence of family problems in patients with PNES suggests that family-related interventions may be useful, but these have not been systematically studied [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psychodynamic interpersonal therapy
         </strong>
         – Psychodynamic interpersonal therapy is an alternative form of psychotherapy. In a case series of 47 patients with PNES, this intervention was associated with seizure remission in 25 percent and a &gt;50 percent seizure reduction in 40 percent [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Response to psychiatric or psychological interventions is variable [
         <a href="#rid4">
          4,47
         </a>
         ]. Interventions are often individualized according to the underlying psychiatric diagnosis (or psychological formulation). We have used a "toolbox" approach, whereby initial triage identifies issues that are thought to be causative, and a therapy type or types is chosen accordingly. As an example, when social factors predominate in causing or maintaining PNES, then family therapy, interpersonal therapy, or social interventions may be used, whereas where reaction to past trauma is prominent, mindfulness, counseling, and acceptance and commitment therapy might be used [
         <a href="#rid26">
          26
         </a>
         ]. Whatever approach is taken, treatment recommendations are mostly based upon clinical experience and the results of observational studies; there have been few randomized treatment trials for PNES [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         The evaluation of talking therapies (ie, psychotherapies) in PNES is challenging. Patients tend not to agree to take part in trials and may comply poorly with trial protocols. Trial design can also be challenging: the choice of control intervention can be difficult, and the opportunity for blinding is limited. The psychiatric conditions associated with or underlying PNES are variable [
         <a href="#rid1">
          1
         </a>
         ], and the relevance of subgroup issues to treatment choice is not well understood. All these factors limit the quantity and quality of evidence available for evaluation of therapies.
        </p>
        <p>
         Barriers to effective treatment of PNES patients also include unwillingness to accept a psychological diagnosis or attend therapy, poor compliance, financial and insurance-related limitations, and difficulty finding psychiatric and psychological clinicians who are experienced and comfortable with PNES.
        </p>
        <p class="headingAnchor" id="H658732986">
         <span class="h2">
          Role of pharmacotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not treat PNES using pharmacotherapy. Antidepressants and anxiolytics may be prescribed on an individualized basis but have had mixed results in open-label studies of PNES [
         <a href="#rid40">
          40,48,49
         </a>
         ]. In a pilot study, 38 patients with PNES were randomly assigned to treatment with flexible-dose
         <a class="drug drug_general" data-topicid="9886" href="/z/d/drug information/9886.html" rel="external">
          sertraline
         </a>
         or placebo [
         <a href="#rid50">
          50
         </a>
         ]. Active treatment was associated with a nonsignificant reduction in PNES frequency. Another pilot study found no benefit of sertraline except when combined with CBT [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3330697451">
         <span class="h1">
          DRIVING SAFETY
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are few data regarding driving safety in patients with PNES, and the little available evidence has not demonstrated that patients with PNES are at increased risk of motor vehicle crashes [
         <a href="#rid2">
          2,51-54
         </a>
         ].
        </p>
        <p>
         However, patients often report that their events are sudden and unpredictable, and in some territories (including New Zealand), this mandates a stand down from driving independent of diagnosis. We advise three months free of events before driving can resume. Guidance that follows a more individualized model has been published in the form of an International League Against Epilepsy Task Force report [
         <a href="#rid55">
          55
         </a>
         ]. Clearly, the foregoing applies when the diagnosis of PNES is confirmed and there is confidence that there is not a comorbid epilepsy.
        </p>
        <p class="headingAnchor" id="H2610768137">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prognosis for patients with PNES is guarded. Many patients will continue to have PNES after diagnosis and treatment. Even patients whose PNES cease may have substantial psychiatric morbidity and functional limitations long term.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizure freedom
         </strong>
         – Most studies that have assessed the prognosis in patients after PNES diagnosis suggest that only a minority (25 to 38 percent) of patients achieve seizure freedom [
         <a href="#rid8">
          8,10,14,27,56,57
         </a>
         ]. Early studies were small and suggested a better prognosis for PNES in children [
         <a href="#rid58">
          58,59
         </a>
         ]. This was supported by one larger study, which reported that 66 percent of 90 children were in remission at two years [
         <a href="#rid60">
          60
         </a>
         ]. However, a later report of 63 children referred to a PNES clinic found that the rate of seizure remission at one year was only 32 percent [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psychiatric and psychosocial status
         </strong>
         – While outcome is often reported as a percent of those with seizure remission, this narrow measure does not necessarily reflect the overall clinical outcome with respect to psychiatric and psychosocial status [
         <a href="#rid27">
          27,31,56,62
         </a>
         ]. As an example, in one study, 56 percent of patients overall continued to depend on state-supported financial benefits at four years after PNES diagnosis [
         <a href="#rid27">
          27,56
         </a>
         ]. The percentage was lower, but still substantial (43 percent), among those in episode remission. Other studies have also found that occupational status, while more likely to improve if PNES cease, often does not improve, even when episodes remit [
         <a href="#rid63">
          63,64
         </a>
         ]. Some studies suggest that psychosocial issues and depression, rather than persistent PNES, are more directly related to disability and reduced quality of life [
         <a href="#rid31">
          31,65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk of suicide
         </strong>
         – Both attempted and successful suicides have been reported in some series with follow-up [
         <a href="#rid31">
          31,63,66
         </a>
         ]. In one of these cohorts, suicide attempts were equally frequent (11 of 56 patients overall) in those with or without seizure remission [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mortality
         </strong>
         – Several studies suggest that there may be a modest increase in premature mortality in patients with PNES [
         <a href="#rid67">
          67-69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Development of new complaints
         </strong>
         – Some patients may develop new somatic complaints after remission of PNES, especially headaches [
         <a href="#rid70">
          70
         </a>
         ]. Other studies suggest that development of new somatic complaints is uncommon and similarly frequent in those with persistent PNES versus PNES in remission [
         <a href="#rid14">
          14,71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Predictors of outcome
         </strong>
         – Many cohort studies have examined potential predictors of outcome, generally focusing on seizure outcome. The results of this exercise have been quite variable and may be affected by the compositions of cohorts, the datasets, methods of analysis, and other factors. Some factors inconsistently associated with a worse prognosis include [
         <a href="#rid3">
          3,10,12,14,23,27,38,57,63,72-75
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Longer duration of symptoms
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Older age at onset
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lower educational level, lower intelligence quotient
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         More isolation, more limited family support
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dependent lifestyle
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         No formal treatment plan
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unrelieved stressors (eg, ongoing abuse, family conflict)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anger, rejection of PNES diagnosis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         More severe underlying psychiatric disorder, especially severe or generalized somatization or dissociative symptoms
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         There is no consistent association between clinical semiology (which may in any event change with time) [
         <a href="#rid12">
          12,76
         </a>
         ] and prognosis [
         <a href="#rid75">
          75,77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H880135494">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Psychogenic nonepileptic seizures (PNES) are events thought to have mainly psychologic origins. PNES include a variety of clinical manifestations, some of which are suggestive, although not independently diagnostic, in distinguishing PNES from other differential diagnoses  (
         <a class="graphic graphic_table graphicRef131637 graphicRef131638" href="/z/d/graphic/131637.html" rel="external">
          table 1A-B
         </a>
         ). The diagnosis of PNES is generally established by video-electroencephalography (EEG) monitoring. The clinical features and diagnosis of PNES are reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of PNES, once established, should be presented to patients and their families in a supportive, nonjudgmental fashion. (See
         <a class="local">
          'Explaining the diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with a diagnosis of PNES only (ie, no epilepsy), antiseizure medications should be gradually withdrawn, with appropriate supervision. (See
         <a class="local">
          'Withdrawal of antiseizure medication'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neurologic follow-up should be maintained after a diagnosis of PNES to monitor the safe withdrawal of antiseizure medications, answer patient questions, reinvestigate if new events appear. (See
         <a class="local">
          'Follow-up'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is little evidence for any treatment for PNES. Psychological intervention is mainly used, including CBT approaches. However, evidence from a randomized trial found no benefit of CBT. (See
         <a class="local">
          'Psychotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pharmacotherapy is not effective for PNES but should be used as indicated to treat psychiatric comorbidity. (See
         <a class="local">
          'Role of pharmacotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The prognosis for patients with PNES is guarded. Many patients will continue to have PNES after diagnosis and treatment. Even patients whose PNES cease may have substantial psychiatric morbidity and long-term functional limitations. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3945853370">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges David K Chen, MD, who contributed to earlier versions of this topic review.
        </p>
        <p>
         The editorial staff at UpToDate would also like to acknowledge Alan Ettinger, MD, MBA, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lesser RP. Treatment and Outcome of Psychogenic Nonepileptic Seizures. Epilepsy Curr 2003; 3:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanner AM. More controversies on the treatment of psychogenic pseudoseizures: an addendum. Epilepsy Behav 2003; 4:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowman ES. Nonepileptic seizures: psychiatric framework, treatment, and outcome. Neurology 1999; 53:S84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52:2133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall-Patch L, Brown R, House A, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 2010; 51:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shen W, Bowman ES, Markand ON. Presenting the diagnosis of pseudoseizure. Neurology 1990; 40:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan R. Psychogenic nonepileptic seizures: diagnosis and initial management. Expert Rev Neurother 2010; 10:1803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carton S, Thompson PJ, Duncan JS. Non-epileptic seizures: patients' understanding and reaction to the diagnosis and impact on outcome. Seizure 2003; 12:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mökleby K, Blomhoff S, Malt UF, et al. Psychiatric comorbidity and hostility in patients with psychogenic nonepileptic seizures compared with somatoform disorders and healthy controls. Epilepsia 2002; 43:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenzie P, Oto M, Russell A, et al. Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks. Neurology 2010; 74:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011; 20:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meierkord H, Will B, Fish D, Shorvon S. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology 1991; 41:1643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krumholz A, Niedermeyer E. Psychogenic seizures: a clinical study with follow-up data. Neurology 1983; 33:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanner AM, Parra J, Frey M, et al. Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome. Neurology 1999; 53:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strutt AM, Hill SW, Scott BM, et al. A comprehensive neuropsychological profile of women with psychogenic nonepileptic seizures. Epilepsy Behav 2011; 20:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aboukasm A, Mahr G, Gahry BR, et al. Retrospective analysis of the effects of psychotherapeutic interventions on outcomes of psychogenic nonepileptic seizures. Epilepsia 1998; 39:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farias ST, Thieman C, Alsaadi TM. Psychogenic nonepileptic seizures: acute change in event frequency after presentation of the diagnosis. Epilepsy Behav 2003; 4:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan R, Horwood J, Razvi S, Mulhern S. Psychogenic nonepileptic seizures that remit when the diagnosis is given: Just good luck? Epilepsy Behav 2020; 102:106667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin RC, Gilliam FG, Kilgore M, et al. Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures. Seizure 1998; 7:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razvi S, Mulhern S, Duncan R. Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic. Epilepsy Behav 2012; 23:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin R, Burneo JG, Prasad A, et al. Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology 2003; 61:1791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson R, Isaac CL, Rowse G, et al. What is it like to receive a diagnosis of nonepileptic seizures? Epilepsy Behav 2009; 14:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Selwa LM, Geyer J, Nikakhtar N, et al. Nonepileptic seizure outcome varies by type of spell and duration of illness. Epilepsia 2000; 41:1330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oto M, Espie C, Pelosi A, et al. The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures. J Neurol Neurosurg Psychiatry 2005; 76:1682.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oto M, Espie CA, Duncan R. An exploratory randomized controlled trial of immediate versus delayed withdrawal of antiepileptic drugs in patients with psychogenic nonepileptic attacks (PNEAs). Epilepsia 2010; 51:1994.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan R, Anderson J, Cullen B, Meldrum S. Predictors of 6-month and 3-year outcomes after psychological intervention for psychogenic non epileptic seizures. Seizure 2016; 36:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuber M, Pukrop R, Bauer J, et al. Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol 2003; 53:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berkhoff M, Briellmann RS, Radanov BP, et al. Developmental background and outcome in patients with nonepileptic versus epileptic seizures: a controlled study. Epilepsia 1998; 39:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Testa SM, Lesser RP, Krauss GL, Brandt J. Personality Assessment Inventory among patients with psychogenic seizures and those with epilepsy. Epilepsia 2011; 52:e84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lenio S, Baker S, Watson M, et al. Assessing the hidden burden of psychiatric disease in patients with nonepileptic seizures. Epilepsy Behav 2021; 125:108382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein LH, Deale AC, Mitchell-O'Malley SJ, et al. An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cogn Behav Neurol 2004; 17:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Miller IW, Ryan CE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav 2009; 14:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Baird GL, Barry JJ, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014; 71:997.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Labudda K, Frauenheim M, Miller I, et al. Outcome of CBT-based multimodal psychotherapy in patients with psychogenic nonepileptic seizures: A prospective naturalistic study. Epilepsy Behav 2020; 106:107029.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010; 74:1986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein LH, Robinson EJ, Mellers JDC, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry 2020; 7:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baslet G, Ehlert A, Oser M, Dworetzky BA. Mindfulness-based therapy for psychogenic nonepileptic seizures. Epilepsy Behav 2020; 103:106534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ettinger AB, Dhoon A, Weisbrot DM, Devinsky O. Predictive factors for outcome of nonepileptic seizures after diagnosis. J Neuropsychiatry Clin Neurosci 1999; 11:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martlew J, Pulman J, Marson AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev 2014; :CD006370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Barry JJ. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav 2005; 7:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaroff CM, Myers L, Barr WB, et al. Group psychoeducation as treatment for psychological nonepileptic seizures. Epilepsy Behav 2004; 5:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry JJ, Wittenberg D, Bullock KD, et al. Group therapy for patients with psychogenic nonepileptic seizures: a pilot study. Epilepsy Behav 2008; 13:624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metin SZ, Ozmen M, Metin B, et al. Treatment with group psychotherapy for chronic psychogenic nonepileptic seizures. Epilepsy Behav 2013; 28:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen DK, Maheshwari A, Franks R, et al. Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia 2014; 55:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krawetz P, Fleisher W, Pillay N, et al. Family functioning in subjects with pseudoseizures and epilepsy. J Nerv Ment Dis 2001; 189:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayor R, Howlett S, Grünewald R, Reuber M. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia 2010; 51:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tolchin B, Martino S, Hirsch LJ. Treatment of Patients With Psychogenic Nonepileptic Attacks. JAMA 2019; 321:1967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Devinsky O. The treatment of nonepileptic seizures: historical perspectives and future directions. Epilepsia 2004; 45 Suppl 2:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pintor L, Baillés E, Matrai S, et al. Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders. J Neuropsychiatry Clin Neurosci 2010; 22:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Keitner GI, Papandonatos GD, et al. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology 2010; 75:1166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benbadis SR, Blustein JN, Sunstad L. Should patients with psychogenic nonepileptic seizures be allowed to drive? Epilepsia 2000; 41:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shneker BF, Elliott JO. Primary care and emergency physician attitudes and beliefs related to patients with psychogenic nonepileptic spells. Epilepsy Behav 2008; 13:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Specht U, Thorbecke R. Should patients with psychogenic nonepileptic seizures be allowed to drive? Recommendations of German experts. Epilepsy Behav 2009; 16:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farooq U, Ahmed S, Madabush J, et al. Survey of physician attitudes towards psychogenic nonepileptic seizures and driving. Epilepsy Behav 2018; 83:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asadi-Pooya AA, Nicholson TR, Pick S, et al. Driving a motor vehicle and psychogenic nonepileptic seizures: ILAE Report by the Task Force on Psychogenic Nonepileptic Seizures. Epilepsia Open 2020; 5:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuber M, Mitchell AJ, Howlett S, Elger CE. Measuring outcome in psychogenic nonepileptic seizures: how relevant is seizure remission? Epilepsia 2005; 46:1788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Massot-Tarrús A, Joe Yu Y, AlKhateeb M, Mirsattari SM. Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit. Epilepsy Behav 2021; 120:108004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wyllie E, Friedman D, Lüders H, et al. Outcome of psychogenic seizures in children and adolescents compared with adults. Neurology 1991; 41:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reilly C, Menlove L, Fenton V, Das KB. Psychogenic nonepileptic seizures in children: a review. Epilepsia 2013; 54:1715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yadav A, Agarwal R, Park J. Outcome of psychogenic nonepileptic seizures (PNES) in children: A 2-year follow-up study. Epilepsy Behav 2015; 53:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fredwall M, Terry D, Enciso L, et al. Outcomes of children and adolescents 1 year after being seen in a multidisciplinary psychogenic nonepileptic seizures clinic. Epilepsia 2021; 62:2528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawton G, Mayor RJ, Howlett S, Reuber M. Psychogenic nonepileptic seizures and health-related quality of life: the relationship with psychological distress and other physical symptoms. Epilepsy Behav 2009; 14:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ettinger AB, Devinsky O, Weisbrot DM, et al. A comprehensive profile of clinical, psychiatric, and psychosocial characteristics of patients with psychogenic nonepileptic seizures. Epilepsia 1999; 40:1292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walczak TS, Papacostas S, Williams DT, et al. Outcome after diagnosis of psychogenic nonepileptic seizures. Epilepsia 1995; 36:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Syc S. Depression and symptoms affect quality of life in psychogenic nonepileptic seizures. Neurology 2009; 73:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savard G, Andermann F, Teitelbaum J, Lehmann H. Epileptic Munchausen's syndrome: a form of pseudoseizures distinct from hysteria and malingering. Neurology 1988; 38:1628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan R, Oto M, Wainman-Lefley J. Mortality in a cohort of patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2012; 83:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nightscales R, McCartney L, Auvrez C, et al. Mortality in patients with psychogenic nonepileptic seizures. Neurology 2020; 95:e643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang L, Beghi E, Tomson T, et al. Mortality in patients with psychogenic non-epileptic seizures a population-based cohort study. J Neurol Neurosurg Psychiatry 2022; 93:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ettinger AB, Devinsky O, Weisbrot DM, et al. Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures. Seizure 1999; 8:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKenzie PS, Oto M, Graham CD, Duncan R. Do patients whose psychogenic non-epileptic seizures resolve, 'replace' them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry 2011; 82:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reuber M, Elger CE. Psychogenic nonepileptic seizures: review and update. Epilepsy Behav 2003; 4:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lesser RP. Psychogenic seizures. Neurology 1996; 46:1499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990; 237:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arain AM, Hamadani AM, Islam S, Abou-Khalil BW. Predictors of early seizure remission after diagnosis of psychogenic nonepileptic seizures. Epilepsy Behav 2007; 11:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaFrance WC Jr, Plioplys S. Neuropsychiatric disorders: does semiology of psychogenic nonepileptic seizures matter? Nat Rev Neurol 2012; 8:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Opherk C, Hirsch LJ. Ictal heart rate differentiates epileptic from non-epileptic seizures. Neurology 2002; 58:636.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 131655 Version 6.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15346150" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Treatment and Outcome of Psychogenic Nonepileptic Seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12791343" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : More controversies on the treatment of psychogenic pseudoseizures: an addendum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10496238" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Nonepileptic seizures: psychiatric framework, treatment, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21955156" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19453708" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2330101" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Presenting the diagnosis of pseudoseizure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21091312" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Psychogenic nonepileptic seizures: diagnosis and initial management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12810341" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Non-epileptic seizures: patients' understanding and reaction to the diagnosis and impact on outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11903468" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Psychiatric comorbidity and hostility in patients with psychogenic nonepileptic seizures compared with somatoform disorders and healthy controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20038774" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21195031" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1922808" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6682198" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Psychogenic seizures: a clinical study with follow-up data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10496249" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21075059" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A comprehensive neuropsychological profile of women with psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9596197" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Retrospective analysis of the effects of psychotherapeutic interventions on outcomes of psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12899864" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Psychogenic nonepileptic seizures: acute change in event frequency after presentation of the diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31846898" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Psychogenic nonepileptic seizures that remit when the diagnosis is given: Just good luck?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9808114" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22093246" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Newly diagnosed psychogenic nonepileptic seizures: health care demand prior to and following diagnosis at a first seizure clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14694050" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19162228" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : What is it like to receive a diagnosis of nonepileptic seizures?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11051130" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Nonepileptic seizure outcome varies by type of spell and duration of illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15944179" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20726877" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : An exploratory randomized controlled trial of immediate versus delayed withdrawal of antiepileptic drugs in patients with psychogenic nonepileptic attacks (PNEAs).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26874857" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Predictors of 6-month and 3-year outcomes after psychological intervention for psychogenic non epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12601698" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9596196" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Developmental background and outcome in patients with nonepileptic versus epileptic seizures: a controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21740416" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Personality Assessment Inventory among patients with psychogenic seizures and those with epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34794013" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Assessing the hidden burden of psychiatric disease in patients with nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15209224" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19233313" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Cognitive behavioral therapy for psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24989152" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32213454" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Outcome of CBT-based multimodal psychotherapy in patients with psychogenic nonepileptic seizures: A prospective naturalistic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20548043" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32445688" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31680023" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Mindfulness-based therapy for psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10570758" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Predictive factors for outcome of nonepileptic seizures after diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24519702" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Psychological and behavioural treatments for adults with non-epileptic attack disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16150653" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Update on treatments of psychological nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15256198" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Group psychoeducation as treatment for psychological nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18621147" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Group therapy for patients with psychogenic nonepileptic seizures: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23680576" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Treatment with group psychotherapy for chronic psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24446955" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11206663" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Family functioning in subjects with pseudoseizures and epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20561022" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31026015" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Treatment of Patients With Psychogenic Nonepileptic Attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15186340" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The treatment of nonepileptic seizures: historical perspectives and future directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21037125" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20739647" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10897163" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Should patients with psychogenic nonepileptic seizures be allowed to drive?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18396464" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Primary care and emergency physician attitudes and beliefs related to patients with psychogenic nonepileptic spells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19853517" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Should patients with psychogenic nonepileptic seizures be allowed to drive? Recommendations of German experts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29705625" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Survey of physician attitudes towards psychogenic nonepileptic seizures and driving.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32913946" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Driving a motor vehicle and psychogenic nonepileptic seizures: ILAE Report by the Task Force on Psychogenic Nonepileptic Seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16302859" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Measuring outcome in psychogenic nonepileptic seizures: how relevant is seizure remission?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33984657" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2027493" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Outcome of psychogenic seizures in children and adolescents compared with adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23944981" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Psychogenic nonepileptic seizures in children: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26580213" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Outcome of psychogenic nonepileptic seizures (PNES) in children: A 2-year follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34339046" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Outcomes of children and adolescents 1 year after being seen in a multidisciplinary psychogenic nonepileptic seizures clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18930164" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Psychogenic nonepileptic seizures and health-related quality of life: the relationship with psychological distress and other physical symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10487194" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A comprehensive profile of clinical, psychiatric, and psychosocial characteristics of patients with psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7588458" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Outcome after diagnosis of psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19652140" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Depression and symptoms affect quality of life in psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3419607" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Epileptic Munchausen's syndrome: a form of pseudoseizures distinct from hysteria and malingering.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22665451" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Mortality in a cohort of patients with psychogenic non-epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32690794" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mortality in patients with psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35086937" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Mortality in patients with psychogenic non-epileptic seizures a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10600584" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21421771" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Do patients whose psychogenic non-epileptic seizures resolve, 'replace' them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of psychogenic non-epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12791321" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Psychogenic nonepileptic seizures: review and update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8649537" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Psychogenic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2319265" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17905668" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Predictors of early seizure remission after diagnosis of psychogenic nonepileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22546703" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Neuropsychiatric disorders: does semiology of psychogenic nonepileptic seizures matter?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11865145" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Ictal heart rate differentiates epileptic from non-epileptic seizures.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
